Merck (MRK) ended the recent trading session at $99.01, demonstrating a +1.42% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.21%. On the other hand, ...

Merck & Co has a lower P/E than the aggregate P/E of 57.45 of the Pharmaceuticals industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that ...

Merck’s MRK stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early November, ...

Members of Congress have traded $MRK stock 15 times in the past 6 months. Of those trades, 6 have been purchases and 9 have been sales. Here’s a breakdown of recent ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the September 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...

Merck (NYSE: MRK) recently announced its first-quarter results, exceeding Wall Street’s expectations for both earnings and revenue. The company reported revenues of $15.53 billion and adjusted ...

Forbes contributors publish independent expert analyses and insights. As a brief background, Merck develops pharmaceutical products for human health across various therapeutic areas and also creates ...

Merck (MRK) has quietly pulled ahead of many pharma peers, with the stock climbing about 22% over the past month and 20% in ...

Merck stock slumps 38% YoY; Q1 earnings could be a pivotal turning point. Analysts see 29% upside despite bearish technicals and weak recent performance. Up Next: Get 5 Dark Horse Stocks Wall Street ...